NEVVI Medicare utilization intelligence
Compare this code with others
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS

Jump to the result views

G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when perfor HCPCS · General Laboratory test
Classification Test › General Laboratory › Immunoassay (CMS RBCS)
First observed 2017
National scale 2,130 services · est. ▲ 51.5% YoY · 1,065 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,067 observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

Included in Explore. Part of a Deep Dive.
Continue from here

Browse Medicare billing by specialty →